These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7318328)

  • 21. Salt sensitivity and central dopaminergic activity in patients with essential hypertension.
    Hamasaki S; Umeda T; Sato T
    Am J Hypertens; 1991 Sep; 4(9):745-51. PubMed ID: 1681822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic factors in human prolactin regulation: a pituitary model for the study of a neuroendocrine system in man.
    Langer G; Sachar EJ; Nathan RS; Tabrizi MA; Perel JM; Halpern FS
    Psychopharmacology (Berl); 1979 Oct; 65(2):161-4. PubMed ID: 117485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Submaximal plasma prolactin response to TRH and dopamine activity in man.
    Spoov J
    Pharmacopsychiatry; 1985 Nov; 18(6):330-2. PubMed ID: 3003766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain dopamine depletion by lesions in the substantia nigra attenuates the development of hypertension in the spontaneously hypertensive rat.
    van den Buuse M; Versteeg DH; de Jong W
    Brain Res; 1986 Mar; 368(1):69-78. PubMed ID: 3006867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic control of thyrotropin, alpha-subunit, thyrotropin beta-subunit, and prolactin in euthyroidism and hypothyroidism: dissociated responses to dopamine receptor blockade with metoclopramide in hypothyroid subjects.
    Scanlon MF; Chan V; Heath M; Pourmand M; Rodriguez-Arnao MD; Weightman DR; Lewis M; Hall R
    J Clin Endocrinol Metab; 1981 Aug; 53(2):360-5. PubMed ID: 7251818
    [No Abstract]   [Full Text] [Related]  

  • 26. [The role of catecholamines in hypertensive mechanisms of essential hypertension].
    Iimura O; Kikuchi K; Yamaji I; Suzuki S; Shimazaki M; Kudo C; Mukai H
    Nihon Rinsho; 1989 Sep; 47(9):1947-55. PubMed ID: 2593268
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of clonidine on central and peripheral nerve tone in primary hypertension.
    Sullivan PA; De Quattro V; Foti A; Curzon G
    Hypertension; 1986 Jul; 8(7):611-7. PubMed ID: 3721561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic control of prolactin secretion in the aging male rat.
    Gudelsky GA; Nansel DD; Porter JC
    Brain Res; 1981 Jan; 204(2):446-50. PubMed ID: 7459639
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence for a dopaminergic involvement in the inhibitory effect of alpha human natriuretic peptide on prolactin in man.
    Foresta C; De Carlo E; Mioni R; Zorzi M; Scandellari C
    Horm Metab Res; 1989 Nov; 21(11):630-4. PubMed ID: 2531718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible involvement of dopaminergic mechanisms in the antimigraine action of flunarizine.
    Piccini P; Nuti A; Paoletti AM; Napolitano A; Melis GB; Bonuccelli U
    Cephalalgia; 1990 Feb; 10(1):3-8. PubMed ID: 2107977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibitory effects of dopamine biosynthesis on the development of spontaneous hypertension in rats].
    Kambara S; Yoshimura M; Yamazaki H; Lee LC; Fukuyama M; Okabayashi H; Nakamura Y; Iyota I; Sasaki S; Takahashi H
    Nihon Jinzo Gakkai Shi; 1986 Oct; 28(10):1377-83. PubMed ID: 3820813
    [No Abstract]   [Full Text] [Related]  

  • 32. Hydergine effect on prolactin and reaction time in dementia.
    el Sobky A; el Shazly M; Darwish AK; Davies T; Griffin K; Keshavan MS
    Biol Psychiatry; 1986 Oct; 21(12):1229-30. PubMed ID: 3756269
    [No Abstract]   [Full Text] [Related]  

  • 33. Alteration in dopaminergic function in abstinent alcoholics.
    Marchesi C; Ampollini P; Chiodera P; Volpi R; Coiro V
    Neuropsychobiology; 1997; 36(1):1-4. PubMed ID: 9211435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Raised plasma-prolactin levels in essential hypertension: index of reduced hypothalamic dopaminergic activity (author's transl)].
    Kolloch R; Stumpe KO; Higuchi M; Vetter H; Krück F
    Klin Wochenschr; 1977 Oct; 55(20):1013-8. PubMed ID: 926711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of central nervous system neurotransmitters in mediating the effects of morphine on growth hormone- and prolactin-secretion in the rat.
    Koenig J; Mayfield MA; Coppings RJ; McCann SM; Krulich L
    Brain Res; 1980 Sep; 197(2):453-68. PubMed ID: 6105900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy.
    Jungmann E; Haak T; Althoff PH; Fassbinder W; Schöffling K
    Arzneimittelforschung; 1988 Feb; 38(2):296-300. PubMed ID: 3285838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of tuberoinfundibular dopaminergic neurons and concentrations of serum prolactin in the rat following lithium administration.
    Gudelsky GA; Koenig JI; Koyama T; Meltzer HY
    Psychopharmacology (Berl); 1988; 94(1):92-6. PubMed ID: 3126532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis.
    De Laurentiis A; Pisera D; Caruso C; Candolfi M; Mohn C; Rettori V; Seilicovich A
    Neuroimmunomodulation; 2002; 10(1):30-9. PubMed ID: 12207161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting pituitary tumors.
    Sarkar DK; Gottschall PE; Meites J
    Science; 1982 Nov; 218(4573):684-6. PubMed ID: 7134966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An abnormal relation between basal prolactin levels and prolactin response to 12.5 microg TRH i.v. in drug-naïve patients with first-episode schizophrenia.
    Spoov J; Bredbacka PE; Stenman UH
    Schizophr Res; 2010 Jun; 119(1-3):41-6. PubMed ID: 20347273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.